Skip to main content

Advertisement

Log in

Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice

  • Liver, Pancreas, and Billiary Tract
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

When heat-killedPropionibacterium acnes was intravenously injected into mice followed by an intravenous injection of a small amount of Gram-negative lipopolysaccharide seven days later, most of the mice died of massive hepatic cell necrosis within 24 hours. However, when irsoglandine maleate, an antiulcer agent, was administered to mice during the period of experimental induction of acute hepatic failure, the survival rate, serum transaminase levels and histological changes of the liver remarkably improved. These results suggested that irsoglandine maleate may have protective effects on the liver in our experimentally-induced acute hepatic failure model using mice. Therefore, in the absence of a definitive therapy for fulminant hepatitis, irsoglandine maleate may be a promising therapeutic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tsutsui H, Mizoguchi Y, Yamamoto S, et al: Studies on experimentally-induced acute hepatic failure: Possible involvement of activated liver adherent cells. In: Kirn A, Knook DL, Wisse E, eds. Cells of the Hepatic Sinusoid, vol 1. The Kupffcr Cell Foundation, The Netherlands. 1986:307–314

    Google Scholar 

  2. Tsutsui H, Mizoguchi Y, Miyajima K, et al: Studies on an experimentally-induced acute hepatic failure in mice. Jpn J Gastroenterol 1986;83:1324–1329 (in Japanese)

    CAS  Google Scholar 

  3. Mizoguchi Y, Tsutsui H, Sakagami Y, et al: Characteristics of the hepatocytotoxic factor in mice with experimentally-induced massive hepatic cell necrosis. Jpn J Allergol 1988;37:959–968

    CAS  Google Scholar 

  4. Ueda F, Aratani S, Mimura K, et al: Effect of 2,4-diamino-6- (2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Arzneim-Forsch 1984;34:474–477

    CAS  Google Scholar 

  5. Okabe S, Takeuchi K, Ishihara Y, et al: Effects of [2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate] (MN-1695) on gastric secretion and on experimental gastric ulcers in rats. Pharmacometrics 1982;24:683–689(in Japanese)

    CAS  Google Scholar 

  6. Ucda F, Hara K, Mimura K, et al: General pharmacology of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695). (3) Effects on the blood coagulation and electrolyte metabolism, and miscellaneous effects. Pharmacometrics 1986; 32:849–860 (in Japanese)

    Google Scholar 

  7. Ueda F, Aratani S, Mimura K, et al: Effect of 2,4-diamino-6- (2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various nccrotizing agents in rats. Arzneim-Forsch 1984;34:478–484

    CAS  Google Scholar 

  8. Ueda F, Watanabe M, Hirata Y, et al: Mechanism for the antiulcer action of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695). Pharmacometrics 1987;33:157–163 (in Japanes)

    CAS  Google Scholar 

  9. Ueda F, Aratani S, Mimura K, et al: Effect of 2,4-diamino-6- (2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal blood flow in dogs. Arzneim-Forsch 1984;34:485–491

    CAS  Google Scholar 

  10. Ueda F, Yano T, Kimura K, et al: Gastric cytoprotection by 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695). In: International Committee of Japanese Society of Gastroenterology, eds. New Trends in Peptic Ulcer and Chronic Hepatitis (Part I). Excerpta Medica Found, Amsterdam 1987;364-370

  11. Mizoguchi Y, Tsutsui H, Miyajima K, et al: The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 1987;7:1184–1188

    Article  PubMed  CAS  Google Scholar 

  12. Mizoguchi Y, Sakagami Y, Seki S, et al: Protective effects of a leukotriene inhibitor in an experimental massive hepatic cell necrosis model. Gastroenterol Jpn 1988;23:263–267

    Article  PubMed  CAS  Google Scholar 

  13. Ohkura Y, Mizoguchi Y, Sakagami Y, et al: Inhibitory effect of TJN-101 ((+)-(6S,7S,R-Biar)-5,6,7,8-tetrahydro-1,2,3,12-tetramethoxy-6,7-dimethyl-10,11-methylenedioxy-6,dibenzo [a,c] cyclooctenol) on immunologically-induced liver injuries. Jpn J Pharmacol 1987;44:179–185

    PubMed  CAS  Google Scholar 

  14. Mizoguchi Y, Kodama C, Arakawa T, et al: Effects of prostaglandin in an experimentally-induced acute hepatic failure model. Jpn J Gastroenterol 1987;84:2558–2562 (in Japanese)

    CAS  Google Scholar 

  15. Abecassis M, Falk R, Blendis L, et al: Treatment of fulminant hepatic failure with a continuous infusion of Prostin VR (PGE1). Hepatology 1987;7:110

    Google Scholar 

  16. Loewenstein WR: Junctional intercellular communication: The cell-to-cell membrane channel. Physiol Rev 1981;61:829–913

    PubMed  CAS  Google Scholar 

  17. Kyoi T, Mimura K, Ueda F, et al: Intercellular communication of cultured rabbit gastric epithelial cells. Jpn J Pharmacol 1989;49(Suppl):192

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mizoguchi, Y., Kawada, N., Ichikawa, Y. et al. Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice. Gastroenterol Jpn 26, 177–181 (1991). https://doi.org/10.1007/BF02811077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02811077

Key words

Navigation